Characterizing the Intraocular Scattering at Different Wavelengths

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Vision, Ocular Clinical Trial

Official title:
Characterizing the Intraocular Scattering at Different Wavelengths

Status Completed

Clinical Trial Summary

This is a single-site, unmasked, 4-visit, randomized 3x3 cross-over clinical trial to quantify intraocular light scatter in different age groups.

n/a

NCT number	NCT05602623
Study type	Interventional
Source	Johnson & Johnson Vision Care, Inc.
Contact
Status	Completed
Phase	N/A
Start date	May 25, 2023
Completion date	May 2, 2024

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT03298737` - Visual Attention and Eye Movements
Not yet recruiting	`NCT05109481` - Masks and Visual Preferences in the Newborn
Recruiting	`NCT06037603` - Dual-Task Exercise for Mild Traumatic Brain Injury (mTBI)	N/A
Active, not recruiting	`NCT02111356` - Determine Functions of Pinhole Glasses on the Eyes	N/A
Active, not recruiting	`NCT04309188` - Stroboscopic Vision Training in Softball	N/A